- Min.Order :0 Metric Ton
- Purity: pure
Keywords
Vildagliptin 274901-16-5
Quick Details
- Appearance:
- Application:
- PackAge:
- ProductionCapacity:|Metric Ton|Day
- Storage:
- Transportation:
Superiority:
Q2 2013
Details:
Vildagliptin (previously identified as LAF237, trade names Zomelis, Galvus) is anal anti-hyperglycemic agent (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitclass of drugs. Vildagliptin inhibits the inactivation of GLP-1[2][3] GIP[3] by DPP-4, allowing GLP-1 GIP to potentiate the secretion of insulin in the beta cells suppress glucagon release by the alpha cells of the islets of Langerhans in the pancreas.
Vildagliptin has been shown to reduce hyperglycemia in type 2 diabetes mellitus.
You Might Also Like
Related Searches
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View